🔎 Trials Near Me

Почетна › Беркитов лимфом › Džordžija › Atlanta

Kliničke studije za Беркитов лимфом u gradu Atlanta, GA

13 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Atlanta i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Тражи се учесникФаза 1
  • Arthur M Blank Hospital, Atlanta
Узраст од 0 до 18 · Оба пола · Ажурирано 13. 11. 2026. · NCT06173518

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Тражи се учесникФаза 2
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Узраст од 18 до 39 · Оба пола · Ажурирано 3. 11. 2026. · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Тражи се учесникОпсервациона студија
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Тражи се учесникФаза 1/2
  • Research Site, Atlanta
Узраст 12 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06137118

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 1
  • Winship Cancer Institute Emory University, Atlanta
  • Northside Hospital Cancer Institute, Atlanta
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT03666000

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Тражи се учесникФаза 2
  • Children's Healthcare of Atlanta at Egleston, Atlanta
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Тражи се учесникФаза 1
  • Winship Cancer Institute, Emory University, Atlanta
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2025. · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Тражи се учесникФаза 2
  • Children's Healthcare of Atlanta, Atlanta
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Atlanta

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.